In silico analysis of long non-coding RNAs in medulloblastoma and its subgroups
Abstract
Medulloblastoma is the most common malignant pediatric brain tumor with high fatality rate. Recent large-scale studies utilizing genome-wide technologies have sub-grouped medulloblastomas into four major subgroups: wingless (WNT), sonic hedgehog (SHH), group 3, and group 4. However, there has yet to be a global analysis of long non-coding RNAs, a crucial part of the regulatory transcriptome, in medulloblastoma. Here, we performed bioinformatic analysis of RNA-seq data from 175 medulloblastoma patients. Differential lncRNA expression sub-grouped medulloblastomas into the four main molecular subgroups. Some of these lncRNAs were subgroup-specific, with a random forest-based machine-learning algorithm identifying an 11-lncRNA diagnostic signature. We also validated the diagnostic signature in patient derived xenograft (PDX) models. We further identified a 17-lncRNA prognostic model using LASSO based penalized Cox PH model (Score HR= 13.6301, 95% CI= 8.857-20.98, logrank p-value=< 2e-16). Our analysis represents the first global lncRNA analysis in medulloblastoma. Our results identify putative candidate lncRNAs that could be evaluated for their functional role in medulloblastoma genesis and progression or as diagnostic and prognostic biomarkers.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The long non-coding RNA lnc-HLX-2-7 is oncogenic in group 3 medulloblastomas
K. Katsushima, B. Lee, … R. J. Perera·Neuro-OncologyPeer-reviewed·Oct 17, 2020
- A circuit involving the lncRNA MB3 and the driver genes MYC and OTX2 inhibits apoptosis in Group 3 Medulloblastoma by regulating the TGF-β pathway via HMGN5
Alessia Grandioso, Paolo Tollis, … Pietro Laneve·Cell Death and DiseasePeer-reviewed·Nov 6, 2025
- LncRNA Miat and Metadhedrin maintain a treatment resistant stem-like niche of medulloblastoma cells
K.-L. Peng, H. N. Vasudevan, … A. M. Schmitt·bioRxiv·Sep 23, 2021
- Comprehensive analysis of lncRNAs reveals candidate prognostic biomarkers in multiple cancer types
K. Isaev, L. Jiang, … J. Reimand·bioRxiv·Dec 2, 2019
- Integrated transcriptomic landscape of medulloblastoma and ependymoma reveals novel tumor subtype-specific biology
Sonali Arora, Nicholas Nuechterlein, … Eric C. Holland·Neuro-OncologyPeer-reviewed·Oct 18, 2025
- Frequent lncRNA-derived fusions in pediatric neuroblastoma identified by LncFusion: potential biomarker and therapeutic implications